Non-targeted profiling of lipids during kainate-induced neuronal injury

FASEB Journal

Volumn 20, Issue 8, 2006, Pages 1152-1161

  Xue, Li Guan ^a   He, Xin ^a   Ong, Wei Yi ^a   Wee, Kiang Yeo ^a   Shui, Guanghou ^a   Wenk, Markus R ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Ceramide; Lipidomics; Mass spectrometry; N acylated phosphatidylethanolamine; Neurotoxicity

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; CERAMIDE; KAINIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; AMINO ACID RECEPTOR STIMULATING AGENT; LIPID; SPHINGOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; LIPID METABOLISM; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; ANIMAL; BRAIN; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; METABOLISM; NERVE CELL; WISTAR RAT;

ANIMALS; BRAIN; CERAMIDES; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; LIPID METABOLISM; LIPIDS; NEURONS; PHOSPHATIDYLETHANOLAMINES; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOLIPIDS;

EID: 33746014977     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-5362com     Document Type: Article

References (42)

1. Lipton, S. A., and Rosenberg, P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622
2. Farooqui, A. A., Horrocks, L. A., and Farooqui, T. (2000) Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106, 1-29
3. Farooqui, A. A., Ong, W. Y., and Horrocks, L. A. (2004) Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4, 85-96
4. Ben-Ari, Y., and Cossart, R. (2000) Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23, 580-587
5. Lu, X. R., Ong, W. Y., Halliwell, B., Horrocks, L. A., and Farooqui, A. A. (2001) Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices. Free Radic. Biol. Med. 30, 1263-1273
6. Ong, W. Y., Lu, X. R., Ong, B. K., Horrocks, L. A., Farooqui, A. A., and Lim, S. K. (2003) Quinacrine abolishes increases in cytoplasmic phospholipase A2 mRNA levels in the rat hippocampus after kainate-induced neuronal injury. Exp. Brain Res. 148, 521-524
7. Thwin, M. M., Ong, W. Y., Fong, C. W., Sato, K., Kodama, K., Farooqui, A. A., and Gopalakrishnakone, P. (2003) Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum. Exp. Brain Res. 150, 427-433
8. Kunz, T., and Oliw, E. H. (2001) The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13, 569-575
9. Sturley, S. L., Patterson, M. C., Balch, W., and Liscum, L. (2004) The pathophysiology and mechanisms of NP-C disease. Biochim. Biophys. Acta 1685, 83-87
10. Wolozin, B., Brown, J., III, Theisler, C., and Silberman, S. (2004) The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev. 10, 127-146
11. Wenk, M. R. (2005) The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594-610
12. Rapaka, R. S., Piomelli, D., Spiegel, S., Bazan, N., and Dennis, E. A. (2005) Targeted lipidomics: signaling lipids and drugs of abuse. Prostaglandins Other Lipid Mediat. 77, 223-234
13. Ong, W. Y., Goh, E. W., Lu, X. R., Farooqui, A. A., Patel, S. C., and Halliwell, B. (2003) Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury. Brain Pathol. 13, 250-262
14. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
15. Sullards, M. C., and Merrill, A. H., Jr. (2001) Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE. 2001, L1
16. Merrill, A. H., Jr., Sullards, M. C., Allegood, J. C., Kelly, S., and Wang, E. (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36, 207-224
17. Nielsen, N. V., Carstensen, J. M., and Smedsgaard, J. (1998) Alignment of single and multiple wavelength chromatographic profiles for chemometric data analysis using correlation optimised warping. J. Chromatogr. A 805, 17-35
18. Farooqui, A. A., Yi, O. W., Lu, X. R., Halliwell, B., and Horrocks, L. A. (2001) Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res. Rev. 38, 61-78
19. Hansen, H. H., Hansen, S. H., Bjornsdottir, I., and Hansen, H. S. (1999) Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs). J. Mass Spectrom. 34, 761-767
20. Ogretmen, B., and Hannun, Y. A. (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604-616
21. Cowart, L. A., Szulc, Z., Bielawska, A., and Hannun, Y. A. (2002) Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies. J. Lipid Res. 43, 2042-2048
22. Wenk, M. R., and De Camilli, P. (2004) Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. Proc. Natl. Acad. Sci. U. S. A. 101, 8262-8269
23. Rohrbough, J., and Broadie, K. (2005) Lipid regulation of the synaptic vesicle cycle. Nat. Rev. Neurosci. 6, 139-150
24. Farooqui, A. A., Ong, W. Y., and Horrocks, L. A. (2004) Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem. Res. 29, 1961-1977
25. Nakane, M., Kubota, M., Nakagomi, T., Tamura, A., Hisaki, H., Shimasaki, H., and Ueta, N. (2000) Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus. Neurosci. Lett. 296, 89-92
26. Rao, A. M., Hatcher, J. F., and Dempsey, R. J. (2000) Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. J. Neurochem. 75, 2528-2535
27. Adibhatla, R. M., Hatcher, J. F., and Dempsey, R. J. (2003) Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox Signal. 5, 647-654
28. Han, X., Yang, J., Cheng, H., Ye, H., and Gross, R. W. (2004) Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal. Biochem. 330, 317-333
29. Forrester, J. S., Milne, S. B., Ivanova, P. T., and Brown, H. A. (2004) Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol. 65, 813-821
30. Balazy, M. (2004) Eicosanomics: targeted lipidomics of eicosanoids in biological systems. Prostaglandins Other Lipid Mediat. 73, 173-180
31. Serhan, C. N. (2005) Mediator lipidomics. Prostaglandins Other Lipid Mediat. 77, 4-14
32. Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres-Becker, I., Berrendero, F., Manzanares, J., Ikonomidou, C., Schmid, H. H., Fernandez-Ruiz, J. J., and Hansen, H. S. (2001) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78, 1415-1427
33. Berger, C., Schmid, P. C., Schabitz, W. R., Wolf, M., Schwab, S., and Schmid, H. H. (2004) Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J. Neurochem. 88, 1159-1167
34. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
35. Ueda, N., Okamoto, Y., and Tsuboi, K. (2005) Endocannabinoid-related enzymes as drug targets with special reference to N- acylphosphatidylethanolamine-hydrolyzing phospholipase D. Curr. Med. Chem. 12, 1413-1422
36. McKinney, M. K., and Cravatt, B. F. (2005) Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411-432
37. Farooqui, A. A., and Horrocks, L. A. (2004) Brain phospholipases A2: a perspective on the history. Prostaglandins Leukot. Essent. Fatty Acids 71, 161-169
38. Cole-Edwards, K. K., and Bazan, N. G. (2005) Lipid signaling in experimental epilepsy. Neurochem. Res. 30, 847-853
39. Wenk, M. R., Lucast, L., Di Paolo, G., Romanelli, A. J., Suchy, S. F., Nussbaum, R. L., Cline, G. W., Shulman, G. I., McMurray, W., and De Camilli, P. (2003) Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat. Biotechnol. 21, 813-817
40. Hisaki, H., Shimasaki, H., Ueta, N., Kubota, M., Nakane, M., Nakagomi, T., Tamura, A., and Masuda, H. (2004) In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death. Brain Res. 1018, 73-77
41. Koybasi, S., Senkal, C. E., Sundararaj, K., Spassieva, S., Bielawski, J., Osta, W., Day, T. A., Jiang, J. C., Jazwinski, S. M., Hannun, Y. A., Obeid, L. M., and Ogretmen, B. (2004) Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279, 44311-44319
42. Schaub, T. M., Hendrickson, C. L., Qian, K., Quinn, J. P., and Marshall, A. G. (2003) High-resolution field desorption/ionization fourier transform ion cyclotron resonance mass analysis of nonpolar molecules. Anal Chem. 75, 2172-2176